Researchers have called it the “Hispanic paradox”: When it comes to breast cancer, prostate cancer and heart disease, Latino patients in the United States survive longer after diagnosis than their non-Latino white and black counterparts.

It’s the same for lung cancer, said scientists at the Miller School of Medicine at the University of Miami in a paper published online this week by the journal Cancer.

Querying a vast database that tracks U.S. cancer cases, the researchers looked at 172,398 patients diagnosed with non-small cell lung cancer, a common subtype of the disease, in the United States from 1988 to 2007.

Overall, the 18,206 Latino patients had a 15 percent lower risk of dying during the study than the non-Latino white patients. Black patients were slightly more likely to die than non-Latino white patients.

The Latino patients were more likely to have less-deadly forms of lung cancer than non-Latino whites or blacks – and less likely to have the most aggressive types of the disease. There were no significant differences in mortality between Latino patients who were born in the United States and those who were born abroad, the study found.

Read the full story at The San Francisco Chronicle